BiondVax Pharmaceuticals Ltd. Short Interest Update
| BVXVDelisted Stock | USD 1.35 0.03 2.17% |
Slightly above 61% of BiondVax Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in BiondVax Pharmaceuticals suggests that many traders are alarmed regarding BiondVax Pharmaceuticals' prospects. BiondVax Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, BiondVax Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
BiondVax |
BiondVax Pharmaceuticals Ltd. was the target of a significant growth in short interest in May. As of May 15th, there was short interest totalling 18,000 shares, a growth of 20.8 percent from the April 30th total of 14,900 shares. Based on an average daily volume of 27,000 shares, the short-interest ratio is
Read at thelincolnianonline.com
 |
BiondVax Pharmaceuticals Fundamental Analysis
We analyze BiondVax Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BiondVax Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BiondVax Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
BiondVax Pharmaceuticals is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
BiondVax Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BiondVax Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of BiondVax Pharmaceuticals could also be used in its relative valuation, which is a method of valuing BiondVax Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
BiondVax Pharmaceuticals Related Equities
| ADTX | Aditxt | 5.56 | ||||
| GOVX | GeoVax Labs | 4.68 | ||||
| ARMP | Armata Pharmaceuticals | 4.46 | ||||
| ANTX | AN2 Therapeutics | 4.35 | ||||
| ATXI | Avenue Therapeutics | 4.30 | ||||
| CANF | Can Fite | 3.95 | ||||
| SABS | SAB Biotherapeutics | 1.95 | ||||
| SLRX | Salarius Pharmaceuticals | 0.60 | ||||
| ORMP | Oramed Pharmaceuticals | 0.42 | ||||
| MOLN | Molecular Partners | 0.19 | ||||
| PHVS | Pharvaris | 0.36 | ||||
| MLYS | Mineralys Therapeutics, | 0.39 | ||||
| MDWD | Mediwound | 0.73 | ||||
| VCNX | Vaccinex | 0.91 | ||||
| KTTA | Pasithea Therapeutics | 2.15 | ||||
| ADIL | Adial Pharmaceuticals | 2.86 | ||||
| RVPH | Reviva Pharmaceuticals | 3.23 | ||||
| BLRX | BioLineRx | 4.35 | ||||
| RNAZ | Transcode Therapeutics | 5.66 | ||||
| SRZN | Surrozen | 5.95 | ||||
| PEPG | PepGen | 8.41 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in BiondVax Stock
If you are still planning to invest in BiondVax Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BiondVax Pharmaceuticals' history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |